Literature DB >> 4056345

Hepatitis B virus multiplication in the absence of usual serological markers. A study of 146 chronic alcoholics.

B Nalpas, P Berthelot, V Thiers, G Duhamel, A M Courouce, P Tiollais, C Brechot.   

Abstract

The possible role of HBV infection in the progression of alcoholic liver disease remains debated. However, serum HBV markers in alcoholics, although present with a high frequency, mainly consist of anti-HBs and/or anti-HBc antibodies. In order to detect an HBV multiplication that could be missed by the usual markers, we looked for HBV-DNA in the serum of 146 chronic alcoholics; the results were compared with those of the usual serological HBV markers. Sixty-eight of the 146 patients could be studied for HBV-DNA both in the liver and the serum. The 146 alcoholics were divided in 48 with normal liver function (group I); 67 with non-cirrhotic alcoholic liver disease (group II); 31 with alcoholic cirrhosis (group III). Among the 146 patients, 17 had a viral multiplication reflected by serum positive HBV-DNA, as against none of 100 healthy controls (P less than 0.01). Six of the 17 had a normal liver function (6/48 = 12.5%), 7 were of group II (7/67 = 10.4%) and 4 had cirrhosis (4/31 = 12.9%). Serum HBV-DNA was associated with HBsAg in 3 occasions; in addition serum HBV-DNA was also present in 5 HBsAg-negative patients with anti-HBc and/or anti-HBs and even in 9 without any usual HBV marker. The overall prevalence of HBV markers in the 146 patients went from 30.8% to 37.0% when serum HBV-DNA was taken into account; it was similar in the 3 groups studied. Eight patients, of the 68 studied, were liver HBV-DNA-positive.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4056345     DOI: 10.1016/s0168-8278(85)80758-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  Detection of hepatitis B virus DNA in serum by polymerase chain reaction amplification and microtiter sandwich hybridization.

Authors:  G H Keller; D P Huang; J W Shih; M M Manak
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

2.  Hepatitis B-related events in autologous hematopoietic stem cell transplantation recipients.

Authors:  Ozcan Ceneli; Zübeyde Nur Ozkurt; Kadir Acar; Seyyal Rota; Sahika Zeynep Aki; Zeynep-Arzu Yeğin; Münci Yağci; Seren Ozenirler; Gülsan Türköz Sucak
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

3.  Serological markers of hepatitis B virus (HBV) infection in alcoholics and hospital controls.

Authors:  P A McCormick; N Ramsay; N Afdhal; A G Shattuck; I B Hillary; D Tubridy; D P O'Donoghue
Journal:  Ir J Med Sci       Date:  1988-03       Impact factor: 1.568

4.  Hepatitis B virus replication in patients with chronic liver diseases.

Authors:  B M Gandhi; M Irshad; S K Acharya; Y K Joshi; B N Tandon
Journal:  Gastroenterol Jpn       Date:  1990-04

5.  Evaluation of the commercially available HepProbe kit for detection of hepatitis B virus DNA in serum.

Authors:  E Valentine-Thon; J Steinmann; W Arnold
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

6.  Screening for hepatitis B virus in healthy blood donors by molecular DNA hybridization analysis.

Authors:  C F Sun; C C Pao; S Y Wu; Y F Liaw
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

7.  Importance of showing HBsAg and HBcAg positivity in the liver for better aetiological definition of chronic liver disease.

Authors:  L Cuccurullo; M Rambaldi; G Iaquinto; F Ferraraccio; L Ambrosone; N Giardullo; A De Vita
Journal:  J Clin Pathol       Date:  1987-02       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.